Zhengye Biotechnology Holding (ZYBT) Invested Capital: 2022-2024
Historic Invested Capital for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Dec 2024 value amounting to $58.5 million.
- Zhengye Biotechnology Holding's Invested Capital was N/A to $61.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $61.7 million, marking a year-over-year change of. This contributed to the annual value of $58.5 million for FY2024, which is 1.36% down from last year.
- Zhengye Biotechnology Holding's Invested Capital amounted to $58.5 million in FY2024, which was down 1.36% from $59.3 million recorded in FY2023.
- In the past 5 years, Zhengye Biotechnology Holding's Invested Capital registered a high of $59.3 million during FY2023, and its lowest value of $53.2 million during FY2022.
- Over the past 3 years, Zhengye Biotechnology Holding's median Invested Capital value was $58.5 million (recorded in 2024), while the average stood at $57.0 million.
- Per our database at Business Quant, Zhengye Biotechnology Holding's Invested Capital increased by 11.58% in 2023 and then fell by 1.36% in 2024.
- Zhengye Biotechnology Holding's Invested Capital (Yearly) stood at $53.2 million in 2022, then increased by 11.58% to $59.3 million in 2023, then declined by 1.36% to $58.5 million in 2024.